Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
Later transplant for renal failure in lupus nephritis may raise graft failure risk
Key clinical point: Delaying transplantation in LN-ESRD patients may do more harm than good, although future studies should determine if longer...
News
Watch for PML after switching from natalizumab to fingolimod
Key clinical point: Natalizumab-related PML risk may persist after switch to fingolimod. Major finding: All PML cases were in patients with prior...
News
Various varicose vein treatments show similar efficacy
Key clinical point: Quality of life outcomes don’t differ substantially between varicose vein treatments. Major finding: The rate of complications...
News
Nurses’ health studies show no link between diet, multiple sclerosis
Key clinical point: Evidence suggests that dietary quality does not influence risk for MS. Major finding: The top vs.
News
Trial probes mechanism of THC-CBD improvement of multiple sclerosis spasticity
Key clinical point: Sativex reduces symptoms of MS spasticity but does not induce corresponding changes on measures of corticospinal excitability...
News
Interferon beta-1a, glatiramer acetate prove cost effective for long-term MS treatment
Key clinical point: Treatment with either glatiramer acetate or interferon beta-1a alters the natural history of relapsing-remitting MS in the...
News
Phase II RADIANCE study results demonstrate efficacy of RPC1036 in MS
Key clinical point: The first clinical trial of the novel oral sphingosine 1-phosphate 1 receptor modulator RPC1063 in patients with relapsing MS...
News
Factors may identify high-risk patients with clinically isolated syndrome
Key clinical point: Risk factor recognition helps in the identification of patients who have clinically isolated syndrome and may benefit from...
News
Alemtuzumab safety and efficacy persist at 4 years in relapsing-remitting multiple sclerosis
Key clinical point: Alemtuzumab appears to be associated with a low rate of sustained accumulation of disability in relapsing-remitting multiple...
News
Autonomic symptoms may contribute to MS-related fatigue
Key clinical point: Patients with relapsing-remitting MS and low disability have autonomic symptoms, particularly orthostatic intolerance, that...
News
Optical coherence tomography appears valuable for tracking MS patients over time
Key clinical point: Ganglion cell layer plus inner plexiform layer (GCIP) atrophy in multiple sclerosis patients can be tracked using optical...